Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895154 · ClinicalTrials.gov registry record · NA
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00895154: Completed NA study, sponsored by Washington University School of Medicine.
NCT00895154 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00895154, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The overall goal of this project is to determine the feasibility of conducting a cognitive intervention for children with sickle cell disease.
Primary Outcome
The WASI is a brief, reliable measure of intelligence. Participants engage in 4 subtests: Block Design, Vocabulary, Similarities, and Matrix Reasoning. Participants receive a raw score on each of these 4 subtests. This raw score is converted to a T score using a score chart in the WASI manual. The T scores from all 4 subtests are summed together to obtain a Full Scale Sum of T Scores. This Full Scale Sum of T Scores is converted to a Full Scale IQ-4 Composite Score using a score chart published
Interventions
- BEHAVIORAL Memory Training
- BEHAVIORAL General Tutoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2003-09 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT00895154 record still lists
NCT00895154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Memory Training is the first listed.
NCT00895154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00895154 about?
NCT00895154 is a clinical study titled "A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study". The overall goal of this project is to determine the feasibility of conducting a cognitive intervention for children with sickle cell disease.
What is the current status of trial NCT00895154?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2003-09. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00895154?
The interventions under investigation include: Memory Training (BEHAVIORAL), General Tutoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT00895154?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00895154's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia